A comparison of AhR+/+ and AhR−/− mice in the combined carcinogen-inflammation (AOM/DSS) model showed that significantly higher levels of overall tumor incidence, the number of adenomas per mouse, tumor volume and the number of adenocarcinomas per mouse were observed in the AhR knockout mice [25]. This evidence concerns the gene AHR and adenocarcinoma.